Park Ha Biological Technology Co., Ltd.
corporate_fare Company Profile
Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) is a publicly traded company in the Life Sciences sector. Wiseek monitors BYAH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Park Ha Biological Prices $2.0M Registered Direct Offering at $1.50/Share, Significant Dilution
- Park Ha Biotech Prices $2M Offering at 17% Discount, Signaling Urgent Capital Need
- Park Ha Biological Forms Strategic AI & Wellness Partnership with Star Plus Legend Subsidiary
- Park Ha Biological Opts Out of Key Nasdaq Governance Rules, Weakening Shareholder Protections
- Park Ha Biological Reports $24.36M Net Loss, Cites Massive Share-Based Compensation & Internal Control Weakness
Financial Snapshot
Insider Transactions
BYAH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.